A new screening tool to detect psychoaffective states in patients with Parkinson´s disease
Objective: To develop a novel screening tool by pooling items from international self-assessment scales detecting psychoaffactive states such as mania, apathy, anxiety, depression and impulse…Non motor symptoms Parkinson’s disease
Objective: 1.To identify the representation and prevalence of non-motor symptoms of PD in the premotor and early motor stages Background: During the period 2016-2018 104 people were…Exploring the Lexicon of Fatigue in Parkinson Disease: A Qualitative Approach
Objective: To understand how patients with Parkinson disease (PD) experience fatigue and identify potential communication barriers between doctors and patients. Background: Fatigue in PD is…Characterization of impulsivity in Colombian patients with Huntington’s disease
Objective: To describe impulsivity in patients with Huntington's disease using a self-report scale and through an objective test of the inhibition capacity. Describe the demographic…Cognitive event related potentials as biomarker of non-motor phenotypes in Parkinson’s Disease
Objective: This research aimed to study the specific changes in cognitive event related potentials (ERP) in patients with different non-motor subtypes of Parkinson’s disease (PD).…Comparison between the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS) and the Non-Motor Symptoms Scale (NMSS)
Objective: To compare the performance of the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS) and its predecessor, the Non-Motor Symptoms Scale (NMSS). Background: The…Long term evolution of ventilatory function in Parkinson’s disease
Objective: To assess the evolution of lung volumes and respiratory muscle strength after a 5 years follow-up in a cohort of patients with Parkinson’s disease…Non-motor symptoms in Parkinson disease motor subtypes: a study using the new MDS-NMS
Objective: To analyze the prevalence and severity of non-motor symptoms (NMS) in Parkinson disease (PD) motor subtypes (tremor-dominant, TD; postural instability/gait disorder, PIGD; and indeterminate),…Seeking regulatory feedback on novel clinical outcome assessments: a case example from the Huntington’s Disease – Regulatory Science Consortium (HD-RSC)
Objective: To align with regulators on the utility and development strategy of novel clinical outcome assessments for use in Huntington’s disease (HD) clinical trials. Background:…Drooling in Parkinson’s Disease: A [123I]FP-CIT SPECT study
Objective: Evaluate the association between drooling and striatal dopamine terminals. Test the assumption that drooling correlates with disease progression in de novo Parkinson’s disease (PD)…
- « Previous Page
- 1
- …
- 31
- 32
- 33
- 34
- 35
- …
- 55
- Next Page »